RNAC
Cartesian Therapeutics Inc.
NASDAQ: RNAC · HEALTHCARE · BIOTECHNOLOGY
$6.22
-3.86% today
Updated 2026-04-30
Market cap
$199.26M
P/E ratio
—
P/S ratio
71.24x
EPS (TTM)
$-5.02
Dividend yield
—
52W range
$6 – $16
Volume
0.2M
Cartesian Therapeutics Inc. (RNAC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.04M | $6.01M | $8.08M | $207000.00 | $903000.00 | $6.68M | $16.60M | $85.08M | $110.78M | $26.00M | $38.91M | $2.80M |
| Revenue growth (YoY) | — | +97.7% | +34.5% | -97.4% | +336.2% | +639.4% | +148.6% | +412.6% | +30.2% | -76.5% | +49.6% | -92.8% |
| Cost of revenue | $17.57M | $14.59M | $15.30M | $45.16M | $47.69M | $42.74M | — | — | $2.04M | $1.55M | — | — |
| Gross profit | $3.04M | $6.01M | $8.08M | $207000.00 | $903000.00 | $6.68M | $16.60M | $85.08M | $108.74M | $26.00M | $38.91M | $2.80M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 98.2% | 100.0% | 100.0% | 100.0% |
| R&D | $10.49M | $22.98M | $29.70M | $45.16M | $47.69M | $42.74M | $54.51M | $68.74M | $72.38M | $71.26M | $45.10M | $58.03M |
| SG&A | $7.95M | $8.34M | $13.05M | $18.83M | $18.24M | $16.39M | $18.91M | $20.94M | $23.86M | $40.45M | $30.13M | $31.47M |
| Operating income | $-15.40M | $-25.30M | $-34.67M | $-63.78M | $-65.02M | $-52.45M | $-56.82M | $-4.60M | $14.54M | $-86.42M | $-43.90M | $-86.70M |
| Operating margin | -506.5% | -421.0% | -428.9% | -30813.5% | -7200.7% | -785.6% | -342.4% | -5.4% | 13.1% | -332.3% | -112.8% | -3099.9% |
| EBITDA | $-11.46M | $-23.18M | $-34.16M | $-63.37M | $-62.87M | $-51.80M | $-65.59M | $-5.16M | $39.84M | $-235.03M | $-75.99M | $-86.70M |
| EBITDA margin | -377.1% | -385.7% | -422.6% | -30611.1% | -6962.0% | -775.9% | -395.2% | -6.1% | 36.0% | -903.8% | -195.3% | -3099.9% |
| EBIT | $-12.33M | $-24.23M | $-34.96M | $-64.11M | $-63.84M | $-53.83M | $-67.32M | $-6.88M | $37.80M | $-235.88M | $-77.14M | — |
| Interest expense | $552000.00 | $948000.00 | $1.25M | $1.21M | $1.49M | $1.52M | $1.56M | $2.84M | $3.03M | $2.83M | $0.00 | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-12.88M | $-25.17M | $-36.21M | $-65.32M | $-65.34M | $-55.35M | $-68.88M | $-25.69M | $35.38M | $-219.71M | $-77.42M | $-130.30M |
| Net income growth (YoY) | — | -95.5% | -43.8% | -80.4% | -0.0% | +15.3% | -24.4% | +62.7% | +237.7% | -721.0% | +64.8% | -68.3% |
| Profit margin | -423.7% | -418.8% | -448.0% | -31556.0% | -7235.4% | -829.0% | -415.0% | -30.2% | 31.9% | -844.9% | -199.0% | -4658.6% |